2023 Form 5500 filing — Relay Therapeutics 401k Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240621074629NAL0002535249001) for Relay Therapeutics 401k Plan, reported by Relay Therapeutics, Inc. under EIN 47-3923475 and plan number 001. It reports 371 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240621074629NAL0002535249001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Relay Therapeutics, Inc.
- EIN
- 47-3923475
- Plan number
- 001
- Location
- Cambridge, MA
- Participants
- 371
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $33,350,379
- Net assets (EOY)
- $33,350,379
- Employer contributions
- $2,633,924
- Participant contributions
- $5,851,062
- Total income / additions
- $14,123,849
- Benefits paid
- $1,465,947
- Administrative expenses
- $81,158
- Total expenses
- $1,547,105
- Net increase / (decrease)
- $12,576,744
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Cambridge Investment Research | BROKER DEALER OF ADVISOR | $59,756 | not reported in the loaded dataset |
| Vanguard | RECORD KEEPER | $23,863 | not reported in the loaded dataset |